Organicell Regenerative Medicine Inc
For the period ended Oct 31, 2023. Filed Jan 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Jan 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 2. PROPERTIES
The Company’s administrative, research, processing and sales and distribution activities are housed in approximately 1,200 square feet of space at the Nova Southeastern University Center for Collaborative Research, 3321 College Avenue, Suite 246, Davie, Florida 33314. This space is occupied pursuant to two-year license agreement with the University that expires on October 9, 2024, for an annual base license fee of $20,230.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.